why choose us

Clinical Trials Search

Showing 7,630 of 132,963 result(s)
Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R;R LBCL

Status: Completed

Condition: Large B-cell Lymphoma

Interventions: Participants will receive radiation therapy to all pretreatment lesions that are able to be feasibly and safely treated.

Date: 2023-10-23

A Study of [14C]-LOXO-783 in Healthy Adult Participants

Status: NOT_YET_RECRUITING

Condition: Healthy

Interventions: Administered orally

Date: 2023-10-23

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome

Status: Completed

Condition: Dravet Syndrome

Interventions: The study drug, fenfluramine HCl, is an oral solution to be administered in equal doses twice daily (BID).
It will be based on the current dose a

Date: 2023-10-23

Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes

Status: NOT_YET_RECRUITING

Condition: type1diabetes

Interventions: Hyperinsulinemic-euglycemic clamp will be used to assess insulin resistance.
After IVs are placed, participants will be transitioned to intraveno

Date: 2023-10-23

A Study to Describe the Characteristics, Health Care Interventions and Outcomes of Patients With Major Bleedings in the Presence of Factor Xa Inhibitor Treatment

Status: Completed

Condition: Major Bleeding

Interventions: Not Applicable since Observational Study

Date: 2023-10-23

Mechanistic Insights From Bronchoscopy Airway Samples

Status: NOT_YET_RECRUITING

Condition: Asthma

Interventions:

Date: 2023-10-23

Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma

Status: Completed

Condition: Glioblastoma

Interventions:

Each patient will undergo a brain MRI at the following time points:

  1. Baseline- within 2 weeks prior to the start of chemo-RT,
  2. Wee

    Date: 2023-10-23

Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility Study

Status: NOT_YET_RECRUITING

Condition: Cardiorenal Syndrome

Interventions: Receipt of 10mg oral dose of dapagliflozin once daily for three days

Date: 2023-10-23

Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches

Status: Completed

Condition: Brain Concussion

Interventions: rTMS will be used to regulate the motor cortex to reduce headaches and post-concussion symptoms.

Date: 2023-10-23